Mustang Bio
在场
Fortress Biotech 是一家在股票代码 FBIO (US) 下上市的公司。
Fortress Biotech 拥有 4家子公司，其中包括 Avenue Therapeutics、Checkpoint Therapeutics 和 Journey Medical Corp。
他们在：
高管
查看带有其 15 名主要高管的组织结构图
Mustang Bio 搜索最多的简介
- Manny Litchman, President, Chief Executive Officer and Director
- Adam Chill, Director
- Michael Zelefsky, Director
创建提醒
跟踪 Mustang Bio 的高管变动
生物技术
Fortress Biotech 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Evommune 刚刚宣布为 115 筹款数百万美元。 (公布2024十一月4号).
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
生物技术 行业的其他推荐联系人
消息
Mustang Bio 的最新新闻稿
- Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
- Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
- Mustang Bio Announces Closing of $4 Million Public Offering
- Mustang Bio Announces Pricing of $4 Million Public Offering
- Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
- Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
- Press Releases
- Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
- View more press releases Close
关于 Mustang Bio 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Greg Furrow 
